vs
Side-by-side financial comparison of Boxlight Corp (BOXL) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Boxlight Corp is the larger business by last-quarter revenue ($29.3M vs $18.3M, roughly 1.6× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -21.1%, a 18.1% gap on every dollar of revenue. On growth, Boxlight Corp posted the faster year-over-year revenue change (-19.2% vs -25.6%). Over the past eight quarters, ROCKWELL MEDICAL, INC.'s revenue compounded faster (-10.1% CAGR vs -23.1%).
Boxlight Corp is a global provider of interactive technology solutions, including interactive flat panel displays, projectors, collaborative software, and classroom technology accessories. It primarily serves K-12 and higher education institutions, as well as corporate and government customers across North America, Europe, and Asia Pacific, focusing on enhancing learning and work collaboration efficiency.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
BOXL vs RMTI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $29.3M | $18.3M |
| Net Profit | $-6.2M | $-554.0K |
| Gross Margin | 29.1% | 21.1% |
| Operating Margin | -13.4% | -2.2% |
| Net Margin | -21.1% | -3.0% |
| Revenue YoY | -19.2% | -25.6% |
| Net Profit YoY | -102.0% | 26.7% |
| EPS (diluted) | $-1.88 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $18.3M | ||
| Q3 25 | $29.3M | $15.9M | ||
| Q2 25 | $30.9M | $16.1M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | $24.0M | $24.7M | ||
| Q3 24 | $36.3M | $28.3M | ||
| Q2 24 | $38.5M | $25.8M | ||
| Q1 24 | $37.1M | $22.7M |
| Q4 25 | — | $-554.0K | ||
| Q3 25 | $-6.2M | $-1.8M | ||
| Q2 25 | $-4.7M | $-1.5M | ||
| Q1 25 | — | $-1.5M | ||
| Q4 24 | $-16.7M | $-756.0K | ||
| Q3 24 | $-3.1M | $1.7M | ||
| Q2 24 | $-1.5M | $343.0K | ||
| Q1 24 | $-7.1M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | 29.1% | 14.3% | ||
| Q2 25 | 35.0% | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | 30.6% | 14.7% | ||
| Q3 24 | 33.8% | 22.0% | ||
| Q2 24 | 37.7% | 17.6% | ||
| Q1 24 | 34.5% | 13.5% |
| Q4 25 | — | -2.2% | ||
| Q3 25 | -13.4% | -9.9% | ||
| Q2 25 | -12.7% | -8.4% | ||
| Q1 25 | — | -7.2% | ||
| Q4 24 | -67.6% | -2.1% | ||
| Q3 24 | -2.4% | 6.8% | ||
| Q2 24 | 3.2% | 2.0% | ||
| Q1 24 | -9.7% | -5.8% |
| Q4 25 | — | -3.0% | ||
| Q3 25 | -21.1% | -11.0% | ||
| Q2 25 | -15.3% | -9.3% | ||
| Q1 25 | — | -8.0% | ||
| Q4 24 | -69.6% | -3.1% | ||
| Q3 24 | -8.4% | 5.9% | ||
| Q2 24 | -3.8% | 1.3% | ||
| Q1 24 | -19.1% | -7.6% |
| Q4 25 | — | $-0.01 | ||
| Q3 25 | $-1.88 | $-0.05 | ||
| Q2 25 | $-1.53 | $-0.05 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | $-87.29 | $-0.02 | ||
| Q3 24 | $-1.72 | $0.04 | ||
| Q2 24 | $-0.92 | $0.01 | ||
| Q1 24 | $-0.76 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.8M | $10.7M |
| Total DebtLower is stronger | $36.7M | — |
| Stockholders' EquityBook value | $-19.5M | $37.0M |
| Total Assets | $99.6M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.7M | ||
| Q3 25 | $11.8M | $13.6M | ||
| Q2 25 | $7.6M | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $8.0M | $15.7M | ||
| Q3 24 | $10.5M | $12.3M | ||
| Q2 24 | $7.5M | $11.9M | ||
| Q1 24 | $11.8M | $6.6M |
| Q4 25 | — | — | ||
| Q3 25 | $36.7M | — | ||
| Q2 25 | $39.0M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $37.1M | — | ||
| Q3 24 | $38.8M | — | ||
| Q2 24 | $40.3M | — | ||
| Q1 24 | $38.5M | — |
| Q4 25 | — | $37.0M | ||
| Q3 25 | $-19.5M | $37.0M | ||
| Q2 25 | $-20.6M | $30.4M | ||
| Q1 25 | — | $31.5M | ||
| Q4 24 | $-12.9M | $32.6M | ||
| Q3 24 | $6.5M | $29.1M | ||
| Q2 24 | $7.5M | $23.5M | ||
| Q1 24 | $9.1M | $20.6M |
| Q4 25 | — | $57.1M | ||
| Q3 25 | $99.6M | $57.5M | ||
| Q2 25 | $99.2M | $52.6M | ||
| Q1 25 | — | $54.0M | ||
| Q4 24 | $115.3M | $59.2M | ||
| Q3 24 | $142.9M | $57.1M | ||
| Q2 24 | $141.3M | $53.0M | ||
| Q1 24 | $142.4M | $50.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.93× | — | ||
| Q2 24 | 5.38× | — | ||
| Q1 24 | 4.23× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.3M | ||
| Q3 25 | $1.3M | $-1.3M | ||
| Q2 25 | — | $1.8M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | $1.6M | $865.0K | ||
| Q3 24 | $5.2M | $4.3M | ||
| Q2 24 | $-5.4M | $1.4M | ||
| Q1 24 | $-1.9M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BOXL
| Products | $27.4M | 93% |
| Services | $2.0M | 7% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
